home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
 |  |  |  |  

Clinical Trials
IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Speakers' bureau
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
Monthly summary of the key literature	in the atherosclerosis field provided each month to all IAS members.
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Computer based algorithms for 10-year risk assessment for cardiovascular disease.
Organizations affiliated with the IAS.

 


IAS-OSLA Course
“LIPID METABOLISM AND CARDIOVASCULAR RISK”

(Muscat, Oman, February 8-10, 2015)




SLIDE LIBRARY

Time February 8th February 9th February 10th
8.30 - 9.30   LDL, HDL and CVD:
Epidemiology and Clinical Trials

Philip BARTER (Australia)
Genetic Approaches to Prevention and Treatment
Philip BARTER (Australia)
9.30 - 10.15 Lipid/Lipoprotein Structure and Metabolism (Overview)
Philip BARTER (Australia)
Agents to Reduce LDL
(and Future Developments)

Raul SANTOS (Brazil)
Non-coronary Forms of Atherosclerosis
Dimitri P MIKHAILIDIS (UK)
10.15 - 11.00 Metabolism and Atherogenic Properties of LDL
Raul SANTOS (Brazil)
Agents to Raise HDL
(and Future Developments)

Jacques GENEST (Canada)
Diabetes, Metabolic Syndrome and CVD
Noor AL-BUSAIDI (Oman)
11.30 - 12.15 Metabolism and Protective Properties of HDL
Jacques GENEST (Canada)
Nutraceuticals in Lipid-Lowering Treatment
Manfredi RIZZO (Italy)
Treatment Guidelines for Lipid Management
Dimitri P MIKHAILIDIS (UK)
12.15 - 13.00 Inflammation and Atherosclerosis
Khamis AL-HASHMI (Oman)
Statin Intolerance
Peter LANSBERG (The Netherlands)
Women’s Health and Heart Disease
Wael ALMAHMEED (UAE)


Lipid/Lipoprotein Structure and Metabolism (Overview)


Philip BARTER
Centre for Vascular Research
University of New South Wales
Sydney, Australia
p.barter@unsw.edu.au

Metabolism and Atherogenic Properties of LDL


Raul SANTOS
Lipid Clinic Heart Institute (InCor)
University of São Paulo Medical School Hospital
São Paulo, Brazil
rdsf@uol.com.br
raul.santos@incor.usp.br

Metabolism and Protective Properties of HDL


Jacques GENEST
McGill University Health Center/Royal Victoria Hospital
McGill University
Montreal, Canada
Jacques.genest@mcgill.ca

Inflammation and Atherosclerosis


Khamis AL-HASHMI
College of Medicine & Health Science
Sultan Qaboos University
Muscat, Oman
kh@squ.edu.om

LDL, HDL and CVD:
Epidemiology and Clinical Trials


Philip BARTER
Centre for Vascular Research
University of New South Wales
Sydney, Australia
p.barter@unsw.edu.au

Agents to Reduce LDL
(and Future Developments)


Raul SANTOS
Lipid Clinic Heart Institute (InCor)
University of São Paulo Medical School Hospital
São Paulo, Brazil
rdsf@uol.com.br
raul.santos@incor.usp.br

Agents to Raise HDL
(and Future Developments)


Jacques GENEST
McGill University Health Center/Royal Victoria Hospital
McGill University
Montreal, Canada
Jacques.genest@mcgill.ca

Nutraceuticals in Lipid-Lowering Treatment


Manfredi RIZZO
BioMedical Department of Internal Medicine and Medical Specialties
School of Medicine, University of Palermo
Palermo, Italy
manfredi.rizzo@unipa.it

Statin Intolerance


Peter LANSBERG
CTMM TraIT – PSI
Centre for Translational and Molecular Medicine (CTMM) – Translational IT (TraIT) Infrastructure
Amsterdam, The Netherlands
Afd. Vasculaire Geneeskunde AMC
Amsterdam
The Netherlands
lansberg@gmail.com

Genetic Approaches to Prevention and Treatment


Philip BARTER
Centre for Vascular Research
University of New South Wales
Sydney, Australia
p.barter@unsw.edu.au

Non-coronary Forms of Atherosclerosis


Dimitri P MIKHAILIDIS
Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
London, UK
MIKHAILIDIS@aol.com

Diabetes, Metabolic Syndrome and CVD


Noor AL-BUSAIDI
National Diabetes & Endocrine Center
Royal Hospital
Ministry of Health
Muscat, Oman
dralbusaidi@hotmail.com

Treatment Guidelines for Lipid Management


Dimitri P MIKHAILIDIS
Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
London, UK
MIKHAILIDIS@aol.com

Women’s Health and Heart Disease


Wael ALMAHMEED
Institute of Cardiac Sciences
in Sheikh Khalifa Medical City
Abu Dhabi, United Arab Emirates
wmahmeed@emirates.net.ae
wmahmeed@gmail.com